by According to Precedence Research, during the forecast period of 2022 to 2030, the global healthcare BPO market is estimated to develop at a compound annual growth rate (CAGR) of 9.49%. The global healthcare BPO market was valued at USD 334.15 billion in 2021, and it is predicted to exceed USD 755.76 billion by 2030. The study investigates several elements and their consequences on the growth of the healthcare BPO market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/2014
This report focuses on healthcare BPO market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall healthcare BPO market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Healthcare BPO Market
| Report Coverage | Details |
| Market Size in 2022 | USD 365.87 Billion |
| Market Size by 2030 | USD 755.76 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.49% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Provider Service, Payer Service, Life Science Service, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of healthcare BPO, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of healthcare BPO has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the healthcare BPO market.
Some of the prominent players in the healthcare BPO market include:
- Accenture (Ireland)
- Access Healthcare (US)
- Akurate Management Solutions (US)
- Cognizant (US)
- Firstsource Solutions (India)
- GeBBS Healthcare Solutions (US)
- Genpact (US)
- HCL Technologies (India)
- IBM Corporation (US)
- Infosys BPM (India)
- Invensis Technologies (India)
- IQVIA (US)
- Lonza (Switzerland)
- Mphasis (India)
- NTT Data Corporation (Japan)
- Omega Healthcare (India)
- Parexel International (US)
- R1 RCM (US)
- Sutherland Global (US)
- Sykes Enterprises (US)
- Tata Consultancy Services (India)
- UnitedHealth Group (US)
- Wipro (India)
- WNS (Holdings) Limited (India)
- Xerox Corporation (US)
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/2014
Segments Covered in the Report
By Provider Service
- Revenue Cycle Management
- Patient Enrolments
- Patient Care
- Medical Transcription
- Medical Imaging
- Device Monitoring
By Payer Service
- Claims Management
- Claims Adjudication Services
- Claims Settlement Services
- Information Management Services
- Claims Repricing
- Claims Investigation Services
- Claims Indexing Services
- Fraud Detection & Management
- Product Development & Business Acquisition (PDBA)
- Member Management
- Provider Management
- Care Management
- Integrated Front-End Services and Back-office Operations
- Billing and accounts management services
- HR Services
By Life Science Service
- Manufacturing
- R&D
- Non-Clinical Services
- Supply Chain Management & Logistics
- Sales and Marketing Services
- Forecasting
- Performance Reporting
- Analytics
- Research
- Marketing
- Other Non-Clinical Services
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare BPO Market
5.1. COVID-19 Landscape: Healthcare BPO Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare BPO Market, By Provider Service
8.1. Healthcare BPO Market, by Provider Service, 2022-2030
8.1.1 Revenue Cycle Management
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Patient Enrolments
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Patient Care
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare BPO Market, By Payer Service
9.1. Healthcare BPO Market, by Payer Service, 2022-2030
9.1.1. Claims Management
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Product Development & Business Acquisition (PDBA)
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Member Management
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Provider Management
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Care Management
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Integrated Front-End Services and Back-office Operations
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Billing and accounts management services
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.8. HR Services
9.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Healthcare BPO Market, By Life Science Service
10.1. Healthcare BPO Market, by Life Science Service, 2022-2030
10.1.1. Manufacturing
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. R&D
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Non-Clinical Services
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Healthcare BPO Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.1.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.1.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
Chapter 12. Company Profiles
12.1. Accenture (Ireland)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Access Healthcare (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Akurate Management Solutions (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cognizant (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Firstsource Solutions (India)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GeBBS Healthcare Solutions (US)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Genpact (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. HCL Technologies (India)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. IBM Corporation (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Infosys BPM (India)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/2014
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
